Toby Eyre/X
May 18, 2024, 04:13
Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024
Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X:
“Look out for important primary analysis of UK MCL biobank at EHA2024.
Mant et al N=588, Active observation in 38% (N=222) of prospectively identified MCL patients.
Delaying initiation of treatment in indolent Mantel Cell Lymphoma does not worsen survival outcomes versus immediate treatment.
Valid management strategy.”
Source: Toby Eyre/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19